A) Geodon B) Prolixin C) Risperdal D) Zyprexa
A) Clozaril B) Zyprexa C) Invega D) Abilify
A) Invega B) Zyprexa C) Abilify D) Seroquel
A) Abilify B) Risperdal C) Seroquel D) Zyprexa
A) Geodon B) Abilify C) Seroquel D) Risperdal
A) Olanzapine B) Clozapine C) Ziprasidone D) Quetiapine
A) Ziprasidone B) Paliperidone C) Risperidone D) Aripriprazole
A) Risperdal B) Seroquel C) Clozaril D) Geodon
A) Clozapine B) Aripiprazole C) Ziprasidone D) Paliperidone
A) Risperdone B) Olazapine C) Quetiapine D) Paliperidone
A) Aripiprazole and Paliperidone B) Risperidone and Paliperidone C) Clozapine and Risperadone D) Clozapine and Aripiprazole
A) 1-3 B) 1 C) 2-5 D) 4-5
A) 18 B) 24 C) 12 D) 6
A) FALSE B) TRUE
A) Minimize side effects of medication B) Prevent relapse into another psychotic episode C) Develop more adaptive coping skills D) Foster patients' medication compliance
A) one year after discontinuation of medication B) six months after discontinuation of medication C) several weeks after discontinuation of medication D) directly after discontinuation of medication
A) Symmetrel B) Artane C) Thorazine D) Clozaril
A) increased effectiveness for positive, negative, and disorganized symptoms B) weight gain more common C) enhanced efficacy in treatment-resistant patients D) tardive dyskinesia more common
A) Prochlorperazine B) Risperidone C) Haloperiodol D) Clozapine
A) Alcohol B) Stimulants C) Anticonvulsants D) Anxiolitics
A) Beta blockers B) Merperidine C) Alcohol D) Halperiodol
A) Beta blockers B) Antacids C) Nicotine D) Anticonvulsants
A) Alcohol B) Tricyclic antidepressants C) Beta blockers D) SSRIs
A) FALSE B) TRUE
A) Drug holidays B) Alcohol use C) Male gender D) Tobacco use
A) TRUE B) FALSE
A) The more frequent the dose of the antipsychotic medication, the greater the risk for the development of tardive dyskinesia. B) Classic antipsychotic medications present less risk for the development of tardive dyskinesia than atypical antipsychotic medications. C) High potency antipsychotic drugs present greater risk for the development of tardive dyskinesia. D) All antipsychotic drugs but Clozapine present a significant risk for the development of tardive dyskinesia.
A) Akathesia B) Acute dystonia C) Akinesia D) Ataxia
A) Agranulocytosis B) Gynecomastia C) Postural hypotension D) Neuroleptic Malignant Syndrome
A) FALSE B) TRUE
A) TRUE B) FALSE
A) antagonize the normal dopamine-mediated inhibition of prolactin release. B) block D2 receptors in the pituitary gland and inhibit prolactin secretion. C) agonize the normal dopamine-mediated inhibition of prolactin release. D) block D2 receptors in the pituitary gland and decrease prolactin secretion.
A) neuroendocrine changes B) hungry hungry hippos C) molecular structure D) receptor binding and DA turnover
A) Phenothiazines B) Sleepykoaladones C) Butyrophenones D) Thioxanthenenes
A) Weak; high; lower B) Potent; low; higher C) Weak; high; higher D) Potent; low; lower
A) Anhedonia B) Hallucinations C) Formal thought disorder D) Delusions
A) All of the above B) Neurological disorders C) Endocrine disorders D) Autoimmune diseases E) Metabolic disorders
A) Hallucinogens B) Stimulants C) Alcohol D) Opioids E) All of the above
A) FALSE B) TRUE
A) disorganized symptoms of Schizophrenia. B) All of the above. C) negative symptoms of Schizophrenia. D) positive symptoms of Schizophrenia.
A) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine reuptake. B) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine release. C) blocking post-synaptic dopamine receptors and/or inhibiting dopamine release. D) blocking post-synaptic dopamine receptors and/or inhibiting dopamine reuptake.
A) the drug reduces the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. B) the drug increases the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. C) the drug reduces the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. D) the drug increases the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine.
A) increased rates of synthesis B) increased tap dancing C) increased rates of firing D) increased release of dopamine
A) thioxanthenes B) piperazines C) aliphatics D) piperideines
A) menstrual irregularity B) galactorrhea C) all of the above D) genecomastia
A) Cogentin (benztropine) B) Artane (trihexphenidyl) C) Inapsine (droperiodol) D) Symmetrel (amantadine) E) Benadryl (diphenhydramine)
A) TRUE B) FALSE
A) superior impact on positive symptoms B) comparative lack of EPS C) polypharmacy D) actual impact at the biological level
A) Invega B) Clozaril C) Abilify D) Haldol
A) Geodon B) Clorazil C) Risperdal D) Seroquel |